APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exoskeleton Enhancement Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchExoskeleton Enhancement Device Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Exoskeleton Enhancement Device Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Exoskeleton Enhancement Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exoskeleton Enhancement Device Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Exoskeleton Enhancement Device Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Exoskeleton Enhancement Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exoskeleton Enhancement Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Exoskeleton Enhancement Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Exoskeleton Enhancement Device market include Parker Hannifin, US Bionics, ReWalk Robotics, Panasonic, Myomo, LockHeed Martin, Interactive Motion Technologies, Hocoma and Ekso Bionics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Exoskeleton Enhancement Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exoskeleton Enhancement Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exoskeleton Enhancement Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Exoskeleton Enhancement Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Exoskeleton Enhancement Device Segment by Company

Parker Hannifin

US Bionics

ReWalk Robotics

Panasonic

Myomo

LockHeed Martin

Interactive Motion Technologies

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Alter G

Exoskeleton Enhancement Device Segment by Type

Lower

Upper

Full Body

Exoskeleton Enhancement Device Segment by Application

Healthcare

Defense

Others

Exoskeleton Enhancement Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Exoskeleton Enhancement Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Exoskeleton Enhancement Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Exoskeleton Enhancement Device significant trends, drivers, influence factors in global and regions.

6. To analyze Exoskeleton Enhancement Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exoskeleton Enhancement Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exoskeleton Enhancement Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exoskeleton Enhancement Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Exoskeleton Enhancement Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exoskeleton Enhancement Device industry.

Chapter 3: Detailed analysis of Exoskeleton Enhancement Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Exoskeleton Enhancement Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Exoskeleton Enhancement Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Exoskeleton Enhancement Device Industry Trends Table 2. Exoskeleton Enhancement Device Industry Drivers Table 3. Exoskeleton Enhancement Device Industry Opportunities and Challenges Table 4. Exoskeleton Enhancement Device Industry Restraints Table 5. Global Exoskeleton Enhancement Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Exoskeleton Enhancement Device Revenue Share by Company (2021-2026) Table 7. Global Exoskeleton Enhancement Device Sales Volume by Company (Units) & (2021-2026) Table 8. Global Exoskeleton Enhancement Device Sales Volume Share by Company (2021-2026) Table 9. Global Exoskeleton Enhancement Device Average Price (K US$/Unit) of Company (2021-2026) Table 10. Global Exoskeleton Enhancement Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Exoskeleton Enhancement Device Key Company Manufacturing Base & Headquarters Table 12. Global Exoskeleton Enhancement Device Company, Product Type & Application Table 13. Global Exoskeleton Enhancement Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Exoskeleton Enhancement Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lower Table 18. Significant Companies of Upper Table 19. Significant Companies of Full Body Table 20. Global Exoskeleton Enhancement Device Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Exoskeleton Enhancement Device Sales Volume by Type (2021-2026) & (Units) Table 22. Global Exoskeleton Enhancement Device Sales Volume by Type (2027-2032) & (Units) Table 23. Global Exoskeleton Enhancement Device Sales Volume Share by Type (2021-2026) Table 24. Global Exoskeleton Enhancement Device Sales Volume Share by Type (2027-2032) Table 25. Global Exoskeleton Enhancement Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Exoskeleton Enhancement Device Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Exoskeleton Enhancement Device Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Exoskeleton Enhancement Device Sales Value Share by Type (2021-2026) Table 29. Global Exoskeleton Enhancement Device Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Healthcare Table 31. Significant Companies of Defense Table 32. Significant Companies of Others Table 33. Global Exoskeleton Enhancement Device Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Exoskeleton Enhancement Device Sales Volume by Application (2021-2026) & (Units) Table 35. Global Exoskeleton Enhancement Device Sales Volume by Application (2027-2032) & (Units) Table 36. Global Exoskeleton Enhancement Device Sales Volume Share by Application (2021-2026) Table 37. Global Exoskeleton Enhancement Device Sales Volume Share by Application (2027-2032) Table 38. Global Exoskeleton Enhancement Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Exoskeleton Enhancement Device Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Exoskeleton Enhancement Device Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Exoskeleton Enhancement Device Sales Value Share by Application (2021-2026) Table 42. Global Exoskeleton Enhancement Device Sales Value Share by Application (2027-2032) Table 43. Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Exoskeleton Enhancement Device Sales by Region (2021-2026) & (Units) Table 45. Global Exoskeleton Enhancement Device Sales Market Share by Region (2021-2026) Table 46. Global Exoskeleton Enhancement Device Sales by Region (2027-2032) & (Units) Table 47. Global Exoskeleton Enhancement Device Sales Market Share by Region (2027-2032) Table 48. Global Exoskeleton Enhancement Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Exoskeleton Enhancement Device Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Exoskeleton Enhancement Device Sales Value Share by Region (2021-2026) Table 51. Global Exoskeleton Enhancement Device Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Exoskeleton Enhancement Device Sales Value Share by Region (2027-2032) Table 53. Global Exoskeleton Enhancement Device Market Average Price (K US$/Unit) by Region (2021-2026) Table 54. Global Exoskeleton Enhancement Device Market Average Price (K US$/Unit) by Region (2027-2032) Table 55. Global Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Exoskeleton Enhancement Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Exoskeleton Enhancement Device Sales by Country (2021-2026) & (Units) Table 58. Global Exoskeleton Enhancement Device Sales Market Share by Country (2021-2026) Table 59. Global Exoskeleton Enhancement Device Sales by Country (2027-2032) & (Units) Table 60. Global Exoskeleton Enhancement Device Sales Market Share by Country (2027-2032) Table 61. Global Exoskeleton Enhancement Device Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Exoskeleton Enhancement Device Sales Value Market Share by Country (2021-2026) Table 63. Global Exoskeleton Enhancement Device Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Exoskeleton Enhancement Device Sales Value Market Share by Country (2027-2032) Table 65. Parker Hannifin Company Information Table 66. Parker Hannifin Business Overview Table 67. Parker Hannifin Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 68. Parker Hannifin Exoskeleton Enhancement Device Product Portfolio Table 69. Parker Hannifin Recent Development Table 70. US Bionics Company Information Table 71. US Bionics Business Overview Table 72. US Bionics Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 73. US Bionics Exoskeleton Enhancement Device Product Portfolio Table 74. US Bionics Recent Development Table 75. ReWalk Robotics Company Information Table 76. ReWalk Robotics Business Overview Table 77. ReWalk Robotics Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 78. ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio Table 79. ReWalk Robotics Recent Development Table 80. Panasonic Company Information Table 81. Panasonic Business Overview Table 82. Panasonic Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 83. Panasonic Exoskeleton Enhancement Device Product Portfolio Table 84. Panasonic Recent Development Table 85. Myomo Company Information Table 86. Myomo Business Overview Table 87. Myomo Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 88. Myomo Exoskeleton Enhancement Device Product Portfolio Table 89. Myomo Recent Development Table 90. LockHeed Martin Company Information Table 91. LockHeed Martin Business Overview Table 92. LockHeed Martin Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 93. LockHeed Martin Exoskeleton Enhancement Device Product Portfolio Table 94. LockHeed Martin Recent Development Table 95. Interactive Motion Technologies Company Information Table 96. Interactive Motion Technologies Business Overview Table 97. Interactive Motion Technologies Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 98. Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio Table 99. Interactive Motion Technologies Recent Development Table 100. Hocoma Company Information Table 101. Hocoma Business Overview Table 102. Hocoma Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 103. Hocoma Exoskeleton Enhancement Device Product Portfolio Table 104. Hocoma Recent Development Table 105. Ekso Bionics Company Information Table 106. Ekso Bionics Business Overview Table 107. Ekso Bionics Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 108. Ekso Bionics Exoskeleton Enhancement Device Product Portfolio Table 109. Ekso Bionics Recent Development Table 110. Cyberdyne Company Information Table 111. Cyberdyne Business Overview Table 112. Cyberdyne Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 113. Cyberdyne Exoskeleton Enhancement Device Product Portfolio Table 114. Cyberdyne Recent Development Table 115. B-TEMIA Inc. Company Information Table 116. B-TEMIA Inc. Business Overview Table 117. B-TEMIA Inc. Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 118. B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio Table 119. B-TEMIA Inc. Recent Development Table 120. Alter G Company Information Table 121. Alter G Business Overview Table 122. Alter G Exoskeleton Enhancement Device Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 123. Alter G Exoskeleton Enhancement Device Product Portfolio Table 124. Alter G Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Exoskeleton Enhancement Device Distributors List Table 128. Exoskeleton Enhancement Device Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Exoskeleton Enhancement Device Product Image Figure 2. Global Exoskeleton Enhancement Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Exoskeleton Enhancement Device Sales (2021-2032) & (Units) Figure 5. Global Exoskeleton Enhancement Device Sales Average Price (K US$/Unit) & (2021-2032) Figure 6. Global Exoskeleton Enhancement Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lower Image Figure 10. Upper Image Figure 11. Full Body Image Figure 12. Global Exoskeleton Enhancement Device Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Exoskeleton Enhancement Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Exoskeleton Enhancement Device Sales Volume Share by Type (2021-2032) Figure 15. Global Exoskeleton Enhancement Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Exoskeleton Enhancement Device Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Exoskeleton Enhancement Device Sales Value Share by Type (2021-2032) Figure 18. Healthcare Image Figure 19. Defense Image Figure 20. Others Image Figure 21. Global Exoskeleton Enhancement Device Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Exoskeleton Enhancement Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Exoskeleton Enhancement Device Sales Volume Share by Application (2021-2032) Figure 24. Global Exoskeleton Enhancement Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Exoskeleton Enhancement Device Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Exoskeleton Enhancement Device Sales Value Share by Application (2021-2032) Figure 27. Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Exoskeleton Enhancement Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Exoskeleton Enhancement Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Exoskeleton Enhancement Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 32. North America Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 38. South America Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Exoskeleton Enhancement Device Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Exoskeleton Enhancement Device Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Exoskeleton Enhancement Device Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Exoskeleton Enhancement Device Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Lower
  • Upper
  • Full Body
Applications
  • Healthcare
  • Defense
  • Others
Companies covered
  • Parker Hannifin
  • US Bionics
  • ReWalk Robotics
  • Panasonic
  • Myomo
  • LockHeed Martin
  • Interactive Motion Technologies
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Exoskeleton Enhancement Device Sales Value (2021-2032)
  4. 1.2.2 Global Exoskeleton Enhancement Device Sales Volume (2021-2032)
  5. 1.2.3 Global Exoskeleton Enhancement Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Exoskeleton Enhancement Device Market Dynamics
  1. 2.1 Exoskeleton Enhancement Device Industry Trends
  2. 2.2 Exoskeleton Enhancement Device Industry Drivers
  3. 2.3 Exoskeleton Enhancement Device Industry Opportunities and Challenges
  4. 2.4 Exoskeleton Enhancement Device Industry Restraints
3 Exoskeleton Enhancement Device Market by Company
  1. 3.1 Global Exoskeleton Enhancement Device Company Revenue Ranking in 2025
  2. 3.2 Global Exoskeleton Enhancement Device Revenue by Company (2021-2026)
  3. 3.3 Global Exoskeleton Enhancement Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Exoskeleton Enhancement Device Average Price by Company (2021-2026)
  5. 3.5 Global Exoskeleton Enhancement Device Company Ranking (2024-2026)
  6. 3.6 Global Exoskeleton Enhancement Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Exoskeleton Enhancement Device Company Product Type and Application
  8. 3.8 Global Exoskeleton Enhancement Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Exoskeleton Enhancement Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Exoskeleton Enhancement Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Exoskeleton Enhancement Device Market by Type
  1. 4.1 Exoskeleton Enhancement Device Type Introduction
  2. 4.1.1 Lower
  3. 4.1.2 Upper
  4. 4.1.3 Full Body
  5. 4.2 Global Exoskeleton Enhancement Device Sales Volume by Type
  6. 4.2.1 Global Exoskeleton Enhancement Device Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Exoskeleton Enhancement Device Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Exoskeleton Enhancement Device Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Exoskeleton Enhancement Device Sales Value by Type
  10. 4.3.1 Global Exoskeleton Enhancement Device Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Exoskeleton Enhancement Device Sales Value by Type (2021-2032)
  12. 4.3.3 Global Exoskeleton Enhancement Device Sales Value Share by Type (2021-2032)
5 Exoskeleton Enhancement Device Market by Application
  1. 5.1 Exoskeleton Enhancement Device Application Introduction
  2. 5.1.1 Healthcare
  3. 5.1.2 Defense
  4. 5.1.3 Others
  5. 5.2 Global Exoskeleton Enhancement Device Sales Volume by Application
  6. 5.2.1 Global Exoskeleton Enhancement Device Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Exoskeleton Enhancement Device Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Exoskeleton Enhancement Device Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Exoskeleton Enhancement Device Sales Value by Application
  10. 5.3.1 Global Exoskeleton Enhancement Device Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Exoskeleton Enhancement Device Sales Value by Application (2021-2032)
  12. 5.3.3 Global Exoskeleton Enhancement Device Sales Value Share by Application (2021-2032)
6 Exoskeleton Enhancement Device Regional Sales and Value Analysis
  1. 6.1 Global Exoskeleton Enhancement Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Exoskeleton Enhancement Device Sales by Region (2021-2032)
  3. 6.2.1 Global Exoskeleton Enhancement Device Sales by Region: 2021-2026
  4. 6.2.2 Global Exoskeleton Enhancement Device Sales by Region (2027-2032)
  5. 6.3 Global Exoskeleton Enhancement Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Exoskeleton Enhancement Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Exoskeleton Enhancement Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Exoskeleton Enhancement Device Sales Value by Region (2027-2032)
  9. 6.5 Global Exoskeleton Enhancement Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Exoskeleton Enhancement Device Sales Value (2021-2032)
  12. 6.6.2 North America Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Exoskeleton Enhancement Device Sales Value (2021-2032)
  15. 6.7.2 Europe Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Exoskeleton Enhancement Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Exoskeleton Enhancement Device Sales Value (2021-2032)
  21. 6.9.2 South America Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Exoskeleton Enhancement Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Exoskeleton Enhancement Device Sales Value Share by Country, 2025 VS 2032
7 Exoskeleton Enhancement Device Country-level Sales and Value Analysis
  1. 7.1 Global Exoskeleton Enhancement Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Exoskeleton Enhancement Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Exoskeleton Enhancement Device Sales by Country (2021-2032)
  4. 7.3.1 Global Exoskeleton Enhancement Device Sales by Country (2021-2026)
  5. 7.3.2 Global Exoskeleton Enhancement Device Sales by Country (2027-2032)
  6. 7.4 Global Exoskeleton Enhancement Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Exoskeleton Enhancement Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Exoskeleton Enhancement Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Exoskeleton Enhancement Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Exoskeleton Enhancement Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Exoskeleton Enhancement Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Parker Hannifin
  2. 8.1.1 Parker Hannifin Company Information
  3. 8.1.2 Parker Hannifin Business Overview
  4. 8.1.3 Parker Hannifin Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Parker Hannifin Exoskeleton Enhancement Device Product Portfolio
  6. 8.1.5 Parker Hannifin Recent Developments
  7. 8.2 US Bionics
  8. 8.2.1 US Bionics Company Information
  9. 8.2.2 US Bionics Business Overview
  10. 8.2.3 US Bionics Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 US Bionics Exoskeleton Enhancement Device Product Portfolio
  12. 8.2.5 US Bionics Recent Developments
  13. 8.3 ReWalk Robotics
  14. 8.3.1 ReWalk Robotics Company Information
  15. 8.3.2 ReWalk Robotics Business Overview
  16. 8.3.3 ReWalk Robotics Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 ReWalk Robotics Exoskeleton Enhancement Device Product Portfolio
  18. 8.3.5 ReWalk Robotics Recent Developments
  19. 8.4 Panasonic
  20. 8.4.1 Panasonic Company Information
  21. 8.4.2 Panasonic Business Overview
  22. 8.4.3 Panasonic Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Panasonic Exoskeleton Enhancement Device Product Portfolio
  24. 8.4.5 Panasonic Recent Developments
  25. 8.5 Myomo
  26. 8.5.1 Myomo Company Information
  27. 8.5.2 Myomo Business Overview
  28. 8.5.3 Myomo Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Myomo Exoskeleton Enhancement Device Product Portfolio
  30. 8.5.5 Myomo Recent Developments
  31. 8.6 LockHeed Martin
  32. 8.6.1 LockHeed Martin Company Information
  33. 8.6.2 LockHeed Martin Business Overview
  34. 8.6.3 LockHeed Martin Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 LockHeed Martin Exoskeleton Enhancement Device Product Portfolio
  36. 8.6.5 LockHeed Martin Recent Developments
  37. 8.7 Interactive Motion Technologies
  38. 8.7.1 Interactive Motion Technologies Company Information
  39. 8.7.2 Interactive Motion Technologies Business Overview
  40. 8.7.3 Interactive Motion Technologies Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Interactive Motion Technologies Exoskeleton Enhancement Device Product Portfolio
  42. 8.7.5 Interactive Motion Technologies Recent Developments
  43. 8.8 Hocoma
  44. 8.8.1 Hocoma Company Information
  45. 8.8.2 Hocoma Business Overview
  46. 8.8.3 Hocoma Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hocoma Exoskeleton Enhancement Device Product Portfolio
  48. 8.8.5 Hocoma Recent Developments
  49. 8.9 Ekso Bionics
  50. 8.9.1 Ekso Bionics Company Information
  51. 8.9.2 Ekso Bionics Business Overview
  52. 8.9.3 Ekso Bionics Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ekso Bionics Exoskeleton Enhancement Device Product Portfolio
  54. 8.9.5 Ekso Bionics Recent Developments
  55. 8.10 Cyberdyne
  56. 8.10.1 Cyberdyne Company Information
  57. 8.10.2 Cyberdyne Business Overview
  58. 8.10.3 Cyberdyne Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cyberdyne Exoskeleton Enhancement Device Product Portfolio
  60. 8.10.5 Cyberdyne Recent Developments
  61. 8.11 B-TEMIA Inc.
  62. 8.11.1 B-TEMIA Inc. Company Information
  63. 8.11.2 B-TEMIA Inc. Business Overview
  64. 8.11.3 B-TEMIA Inc. Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 B-TEMIA Inc. Exoskeleton Enhancement Device Product Portfolio
  66. 8.11.5 B-TEMIA Inc. Recent Developments
  67. 8.12 Alter G
  68. 8.12.1 Alter G Company Information
  69. 8.12.2 Alter G Business Overview
  70. 8.12.3 Alter G Exoskeleton Enhancement Device Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Alter G Exoskeleton Enhancement Device Product Portfolio
  72. 8.12.5 Alter G Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Exoskeleton Enhancement Device Value Chain Analysis
  2. 9.1.1 Exoskeleton Enhancement Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Exoskeleton Enhancement Device Sales Mode & Process
  6. 9.2 Exoskeleton Enhancement Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Exoskeleton Enhancement Device Distributors
  9. 9.2.3 Exoskeleton Enhancement Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst